EDIT vs EQR · rev $32.3M vs P/E 26, $26.37B cap
Editas Medicine Inc (EDIT) versus Equity Residential (EQR) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Equity Residential (EQR) is a reit - residential company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
EQR does not have a complete income-statement cache yet.
EDIT currently screens at market cap $375.2M. EQR currently screens at market cap $26.37B and trailing P/E 25.7.
Not investment advice. Open the EDIT and EQR stock pages for the full models.
Not investment advice.